Start › Rak płuc › Teksas › Houston
Badania kliniczne dla Rak płuc w mieście Houston, TX
78 badań dla Rak płuc szuka uczestników w ośrodkach w mieście Houston i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekrutacjaFaza 3
- Houston Methodist Hospital, Houston
- Houston Methodist West Hospital, Houston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekrutacjaFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- UT MD Anderson Cancer Center, Houston
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 2
- The University of Texas MD Anderson Cancer Center, Houston
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RekrutacjaFaza 3
- Houston Methodist Hospital, Houston
- Methodist Willowbrook Hospital, Houston
- Houston Methodist West Hospital, Houston
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
RekrutacjaFaza 1
- The University of Texas MD Anderson Cancer Center, Houston
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RekrutacjaFaza 3
- MD Anderson Cancer Center, Houston
A Study of PHN-012 in Patients With Advanced Solid Tumors
RekrutacjaFaza 1
- PHN-012-001 Site, Houston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- Kelsey Research Foundation, Houston
- Kelsey-Seybold Clinic - North Houston Campus, Houston
- Texas Oncology - Gulf Coast, Houston
- i 5 więcej
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RekrutacjaFaza 3
- Oncology Consultants PA, Houston
- University of Texas MD Anderson Cancer Center, Houston
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekrutacjaFaza 3
- The University of Texas MD Anderson Cancer Center Diagnostic Imaging, Houston
- The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
- The University of Texas, MD Anderson Cancer Center- Interventional Radiology, Houston
- i 3 więcej
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekrutacjaFaza 2
- The University of Texas MD Anderson Cancer Center, Houston
A Registry for People With Lung Cancer
RekrutacjaBadanie obserwacyjne
- MD Anderson Cancer Center (Data Collection Only), Houston
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
RekrutacjaFaza 2/3
- University of Texas MD Anderson Cancer Center, Houston
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
RekrutacjaFaza 2
- Research Site, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekrutacjaFaza 1/2
- MD Anderson, Houston
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
RekrutacjaFaza 2/3
- Local Institution - 0025, Houston
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekrutacjaFaza 1/2
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
RekrutacjaFaza 1
- M D Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekrutacjaFaza 1/2
- MD Anderson Cancer Center, Houston
Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation
Rekrutacja
- M D Anderson Cancer Center, Houston
The Rise in Robotic Atypical Segmentectomies
RekrutacjaBadanie obserwacyjne
- M D Anderson Cancer Center, Houston
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekrutacjaFaza 1
- Oncology Consultants, Houston
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- The University of Texas MD Anderson Cancer Center, Houston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekrutacjaFaza 3
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
- Lumi Research, Houston
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- MD Anderson Cancer Center, Houston
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RekrutacjaFaza 1
- The University of Texas - MD Anderson Cancer Center, Houston
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekrutacjaFaza 1/2
- Avenzo Therapeutics Recruiting Site, Houston
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RekrutacjaFaza 1
- Oncology Consultants Texas Medical Center, Houston
Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy
RekrutacjaFaza 2
- M D Anderson Cancer Center, Houston
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
RekrutacjaFaza 3
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
RekrutacjaFaza 3
- The University of Texas MD Anderson Cancer Center, Houston
Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- The University of Texas M. D. Anderson Cancer Center, Houston
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
RekrutacjaFaza 3
- University of Texas, MD Anderson Cancer Center, Houston
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- Ben Taub General Hospital, Houston
- UT MD Anderson Cancer Center, Houston
- i 1 więcej
Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
Rekrutacja
- M D Anderson Cancer Center, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekrutacjaFaza 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT - Oncology - Houston, Houston
IDOV-Immune for Advanced Solid Tumors
RekrutacjaFaza 1
- MD Anderson Cancer Center, Houston
REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)
RekrutacjaFaza 2
- M D Anderson Cancer Center, Houston
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
RekrutacjaFaza 1/2
- M.D. Anderson Cancer Center (Melanoma/NSCLC), Houston
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
RekrutacjaFaza 1
- M D Anderson Cancer Center, Houston
Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
Rekrutacja
- MD Anderson Cancer Center, Houston
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
RekrutacjaFaza 1
- NEXT Houston, Houston
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekrutacjaFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekrutacjaFaza 1
- The University of Texas MD Anderson Cancer Center, Houston
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
RekrutacjaFaza 2
- M D Anderson Cancer Center, Houston
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
RekrutacjaBadanie obserwacyjne
- M D Anderson Cancer Center, Houston
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
RekrutacjaFaza 2
- M D Anderson Cancer Center, Houston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekrutacjaFaza 1
- Research Site, Houston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekrutacjaFaza 1
- University of Texas, MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekrutacjaFaza 1/2
- MD Anderson Cancer Center, Houston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekrutacjaFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RekrutacjaFaza 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Study of ZW251 in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- MD Anderson Cancer Center, Houston
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
Rekrutacja
- MD Anderson Cancer Center, Houston
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekrutacjaFaza 1/2
- MD Anderson Cancer Center, Houston
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
Rekrutacja
- M D Anderson Cancer Center, Houston
Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes
RekrutacjaBadanie obserwacyjne
- The University of Texas M. D. Anderson Cancer Center, Houston
Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
RekrutacjaZapraszamy zdrowych ochotników
- M D Anderson Cancer Center, Houston
Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners
RekrutacjaZapraszamy zdrowych ochotników
- Memorial Hermann, Houston
- University of Texas MD Anderson Cancer Center, Houston
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
RekrutacjaZapraszamy zdrowych ochotników
- M D Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekrutacjaFaza 1/2
- MD Anderson Cancer Center, Houston
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekrutacjaFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
RekrutacjaZapraszamy zdrowych ochotników
- MD Anderson Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
RekrutacjaBadanie obserwacyjne
- Md Anderson Cancer Center, Houston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Rekrutacja
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekrutacjaFaza 1
- MD Anderson Cancer Center, Houston
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
RekrutacjaFaza 1
- Baylor St. Luke's Medical Center, Houston
Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System
RekrutacjaZapraszamy zdrowych ochotników
- The University of Texas M. D. Anderson Cancer Center, Houston
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
RekrutacjaFaza 1/2
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
RekrutacjaFaza 1
- Oncology Consultants, Houston
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekrutacjaFaza 1/2
- The University of Texas MD Anderson Cancer Center (site 127), Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekrutacjaBadanie obserwacyjne
- Massive Bio SYNERGY-AI site, Houston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RekrutacjaFaza 1/2
- MD Anderson Cancer Center, Houston
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
RekrutacjaBadanie obserwacyjne
- M D Anderson Caner Center, Houston
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
RekrutacjaBadanie obserwacyjne
- Horizon Clinical Research Group, Houston
Comprehensive Outcomes for After Cancer Health
RekrutacjaZapraszamy zdrowych ochotników
- The University of Texas MD Anderson Cancer Center, Houston
- UT Health Houston, Houston
Badania dla Rak płuc w innych miastach
- Boston, MA62 badań
- New York City, NY60 badań
- Los Angeles, CA45 badań
- Washington, DC41 badań
- Arlington, VA41 badań
- Chicago, IL41 badań
- Nashville, TN40 badań
- Baltimore, MD40 badań
- St. Louis, MO39 badań
- Columbus, OH37 badań
- Philadelphia, PA36 badań
- Seattle, WA33 badań
Inne badania w mieście Houston
- Niedrobnokomórkowy rak płuca145 badań
- Rak piersi126 badań
- Nowotwory (wszystkie typy)121 badań
- Nowotwór przerzutowy104 badań
- Rak jelita grubego i odbytnicy102 badań
- Rak jajnika89 badań
- Ostra białaczka szpikowa85 badań
- Rak prostaty76 badań
- Rak endometrium68 badań
- Rak trzustki61 badań
- Czerniak59 badań
- Rak płaskonabłonkowy głowy i szyi47 badań
Źródło: ClinicalTrials.gov, dane pobrane 5 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.